Disturbed Ca2+ signalling and apoptosis of medium spiny neurons in Huntington's disease

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 7, 2005, Pages 2602-2607

  Tang, Tie Shan ^a   Slow, Elizabeth ^b   Lupu, Vitalie ^a   Stavrovskaya, Irina G ^c   Sugimori, Mutsuyuki ^d   Llinás, Rodolfo ^d   Kristal, Bruce S ^c,e   Hayden, Michael R ^a   Bezprozvanny, Ilya ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BURKE MEDICAL RESEARCH INSTITUTE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Enoxaparin; Lovenox; Mitochondria; Neurodegeneration; Transgenic mouse

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; BONGKREKIC ACID; CALCIUM ION; CYTOCHROME C; DESIPRAMINE; ENOXAPARIN; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 5; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MAPROTILINE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NORTRIPTYLINE; RECEPTOR BLOCKING AGENT; RUTHENIUM; RUTHENIUM 360; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; GLUTAMIC ACID;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CAUDATE NUCLEUS; CELL ORGANELLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; HUNTINGTON CHOREA; MEDIUM SPINY NERVE CELL; MEMBRANE PERMEABILITY; MOUSE; NERVE CELL; NEUROPHARMACOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; TRANSGENIC MOUSE; WILD TYPE; YEAST ARTIFICIAL CHROMOSOME; ANIMAL; BACTERIAL ARTIFICIAL CHROMOSOME; BIOLOGICAL MODEL; DISEASE MODEL; DRUG EFFECT; GENETICS; HUMAN; IN VITRO STUDY; METABOLISM; NERVE DEGENERATION; PATHOLOGY;

ANIMALS; APOPTOSIS; CALCIUM SIGNALING; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DISEASE MODELS, ANIMAL; GLUTAMIC ACID; HUMANS; HUNTINGTON DISEASE; MICE; MICE, TRANSGENIC; MODELS, NEUROLOGICAL; NERVE DEGENERATION; NEURONS;

EID: 14044264256     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0409402102     Document Type: Article

References (28)

1. Vonsattel, J. P. & DiFiglia, M. (1998) J. Neuropathol. Exp. Neurol 57, 369-384.
2. The Huntington's Disease Collaborative Research Group (1993) Cell 72, 971-983.
3. Tobin, A. J. & Signer, E. R. (2000) Trends Cell Biol. 10, 531-536.
4. Rubinsztein, D. C. (2002) Trends Genet. 18, 202-209.
5. Slow, E. J., van Raamsdonk, J., Rogers, D., Coleman, S. H., Graham, R. K., Deng, Y., Oh, R., Bissada, N., Hossain, S. M., Yang, Y. Z., et al. (2003) Hum. Mol. Genet. 12, 1555-1567.
6. Chen, N., Luo, T., Wellington, C., Metzler, M., McCutcheon, K., Hayden, M. R. & Raymond, L. A. (1999) J. Neurochem. 12, 1890-1898.
7. Sun, Y., Savanenin, A., Reddy, P. H. & Liu, Y. F. (2001) J. Biol. Chem. 276, 24713-24718.
8. Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R. & Raymond, L. A. (2002) Neuron 33, 849-860.
9. Tang, T.-S., Tu, H., Chan, E. Y., Maximov, A., Wang, Z., Wellington, C. L., Hayden, M. R. & Bezprozvanny, I. (2003) Neuron 39, 227-239.
10. Orrenius, S., Zhivotovsky, B. & Nicotera, P. (2003) Nat. Rev. Mol. Cell Biol. 4, 552-565.
11. Hajnoczky, G., Davies, E. & Madesh, M. (2003) Biochem. Biophys. Res. Commun. 304, 445-454.
12. Bezprozvanny, I. & Hayden, M. R. (2004) Biochem. Biophys. Res. Commun. 322, 1310-1317.
13. Hodgson, J. G., Agopyan, N., Gutekunst, C. A., Leavitt, B. R., LePiane, F., Singaraja, R., Smith, D. J., Bissada, N., McCutcheon, K., Nasir, J., et al. (1999) Neuron 23, 181-192.
14. Lupu, V. D., Kaznacheyeva, E., Krishna, U. M., Falck, J. R. & Bezprozvanny, I. (1998) J. Biol. Chem. 273, 14067-14070.
15. Tang, T. S., Tu, H., Orban, P. C., Chan, E. Y., Hayden, M. R. & Bezprozvanny, I. (2004) Eur. J. Neurosci. 20, 1779-1787.
16. Maruyama, T., Kanaji, T., Nakade, S., Kanno, T. & Mikoshiba, K. (1997) J. Biochem. (Tokyo) 122, 498-505.
17. Jonas, S., Sugimori, M. & Llinás, R. (1997) Ann. N.Y. Acad. Sci. 825, 389-393.
18. Kirichok, Y., Krapivinsky, G. & Clapham, D. E. (2004) Nature 427, 360-364.
19. Ying, W. L., Emerson, J., Clarke, M. J. & Sanadi, D. R. (1991) Biochemistry 30, 4949-4952.
20. Halestrap, A. P., McStay, G. P. & Clarke, S. J. (2002) Biochimie 84, 153-166.
21. Stavrovskaya, I. G., Narayanan, M. V., Zhang, W., Krasnikov, B. F., Heemskerk, J., Young, S. S., Blass, J. P., Brown, A. M., Beal, M. F., Friedlander, R. M. & Kristal, B. S. (2004) J. Exp. Med. 200, 211-222.
22. Landwehrmeyer, G. B., Standaert, D. G., Testa, C. M., Penney, J. B., Jr., & Young, A. B. (1995) J. Neurosci. 15, 5297-5307.
23. Testa, C. M., Standaert, D. G., Landwehrmeyer, G. B., Penney, J. B., Jr., & Young, A. B. (1995) J. Comp. Neurol. 354, 241-252.
24. Panov, A. V., Gutekunst, C. A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J. & Greenamyre, J. T. (2002) Nat. Neurosci. 5, 731-736.
25. Choo, Y. S., Johnson, G. V., MacDonald, M., Detloff, P. J. & Lesort, M. (2004) Hum. Mol. Genet. 13, 1407-1420.
26. Stutzmann, J. M., Mary, V., Wahl, F., Grosjean-Piot, O., Uzan, A. & Pratt, J. (2002) CNS Drug Rev. 8, 1-30.
27. Mary, V., Wahl, F., Uzan, A. & Stutzmann, J. M. (2001) Stroke 32, 993-999.
28. Bergamaschini, L., Rossi, E., Storini, C., Pizzimenti, S., Distaso, M., Perego, C., De Luigi, A., Vergani, C. & De Simoni, M. G. (2004) J. Neurosci. 24, 4181-4186.